M21-404 ABBV-400 Ph1 FIH Advanced Solid Tumors
ClinicalTrials.gov NCT05029882
Research payments
$7,350
Through program year 2024, $7,350 in research payments was reported against M21-404 ABBV-400 Ph1 FIH Advanced Solid Tumors, across 13 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05029882
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $7,350 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Marcia Cruz Correa Rio Piedras, PR Named on 1 payment
- Manish Sharma Grand Rapids, MI Named on 1 payment
- Michael Cecchini New Haven, CT Named on 1 payment
- Yonina Murciano-Goroff New York, NY Named on 1 payment
- David Camidge Aurora, CO Named on 1 payment
- Alexander Spira Fairfax, VA Named on 1 payment
- Bert O Neil Indianapolis, IN Named on 1 payment
- Jonathan Goldman Santa Monica, CA Named on 1 payment
- John Powderly Huntersville, NC Named on 1 payment
- Kanwal Raghav Houston, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.